Search
Search Results
##search.searchResults.foundPlural##
-
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2070PDF: 1114HTML: 7693cover letter paper final AML: 214 -
IMMUNOLOGY OF TUBERCULOSIS
5295PDF: 2002HTML: 7319Untitled: 195 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3885PDF: 756HTML: 1849 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2761PDF: 1118HTML: 3283 -
EXERCISE STRESS ECHOCARDIOGRAPHY WITH TISSUE DOPPLER IMAGING (TDI) DETECTS EARLY SYSTOLIC DYSFUNCTION IN BETA-THALASSEMIA MAJOR PATIENTS WITHOUT CARDIAC IRON OVERLOAD
1316PDF: 808HTML: 7868Manuscript after revision: 242Barbero10328-36310-after revision: 231 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3695PDF: 1442HTML: 182 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3554PDF: 1067HTML: 874 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7959PDF: 4131HTML: 7365 -
-
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1808PDF: 809HTML: 10234Figures 1,2,3: 173 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1600PDF: 580HTML: 385 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4726PDF: 1554HTML: 2251Untitled: 207Untitled: 222Untitled: 230Untitled: 213Untitled: 216 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
205PDF: 214HTML: 13 -
-
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2337PDF: 935HTML: 304 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4801PDF: 1787HTML: 2705Untitled: 215 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4245PDF: 1517HTML: 447 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1418PDF: 901Suppl. Files: 454HTML: 235 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2959PDF: 892HTML: 1949 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
975PDF: 615HTML: 226 -
-
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3149PDF: 1114HTML: 1754 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
723PDF: 465HTML: 6265 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4042PDF: 1151HTML: 1935Fig.1: 219Fig. 2: 111Table 1: 201Table2: 219Table 3: 199 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1002PDF: 669Html: 156 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3936PDF: 1496HTML: 9188Untitled: 277Untitled: 183Untitled: 168Untitled: 164Untitled: 180Untitled: 338 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3251PDF: 935HTML: 2954







